ICON Public Limited Company (ICLR)
NASDAQ: ICLR · Real-Time Price · USD
110.03
+2.83 (2.64%)
At close: Mar 9, 2026, 4:00 PM EDT
110.03
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:10 PM EDT
ICLR Revenue
ICON Public Limited Company had revenue of $2.04B in the quarter ending September 30, 2025, with 0.63% growth. This brings the company's revenue in the last twelve months to $8.10B, down -2.46% year-over-year. In the year 2024, ICON Public Limited Company had annual revenue of $8.28B with 1.99% growth.
Revenue (ttm)
$8.10B
Revenue Growth
-2.46%
P/S Ratio
0.99
Revenue / Employee
$193,380
Employees
41,900
Market Cap
8.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.28B | 161.50M | 1.99% |
| Dec 31, 2023 | 8.12B | 378.79M | 4.89% |
| Dec 31, 2022 | 7.74B | 2.26B | 41.24% |
| Dec 31, 2021 | 5.48B | 2.68B | 95.93% |
| Dec 31, 2020 | 2.80B | -8.55M | -0.30% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Quest Diagnostics | 11.04B |
| Illumina | 4.34B |
| Charles River Laboratories International | 4.02B |
| Exact Sciences | 3.25B |
| Revvity | 2.86B |
| Medpace Holdings | 2.53B |
| Qiagen | 2.09B |
| RadNet | 2.04B |
ICLR News
- 11 days ago - Ademi LLP Investigates Claims of Securities Fraud against ICON plc - GlobeNewsWire
- 12 days ago - ICLR Investors Have Opportunity to Join ICON Public Limited Company Fraud Investigation with the Schall Law Firm - GlobeNewsWire
- 19 days ago - ICON plc Faces Investigation After Internal Probe Reveals Multi-Year Revenue Overstatement - PRNewsWire
- 20 days ago - Diamond Hill International Strategy Q4 2025 Portfolio Review - Seeking Alpha
- 24 days ago - ICON plc (ICLR) Shares Crater Amid Delayed Financial Report, Investigation Into Revenue Recognition Issues - Hagens Berman - PRNewsWire
- 24 days ago - ICON plc (ICLR) Shares Crater Amid Delayed Financial Report, Investigation Into Revenue Recognition Issues – Hagens Berman - GlobeNewsWire
- 25 days ago - Why this drug-research company's stock is having its worst day since 1999 - Market Watch
- 25 days ago - ICON PLC (ICLR) Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewsWire